Hints and tips:
...Joseph Thome, analyst at Cowen, said the oral therapy developed by Seres would be more convenient to administer than Rebyota....
...It was a slim volume, yet we micro-analysed every last semi-colon of its tortured arguments. To do well, we had to find flaws in the philosopher’s reasoning....
...New York-based ImClone said on Wednesday its interim chief executive officer, Joseph Fischer, has resigned and Icahn has been named chairman of the board....
International Edition